Review

Comparison of cytotoxic activity of herbal extracts on the most commonly used breast cancer cell lines (MCF7 and SKBR3): A systematic review

Volume: 24 Number: 1 June 27, 2025
  • Nasrin Dehghan-nayeri *
  • Mina Darvishi
  • Pargol Mashati
  • Maryam Rezapour-kalkhoran
  • Morteza Rezaiefard
  • Samareh Younesian
EN

Comparison of cytotoxic activity of herbal extracts on the most commonly used breast cancer cell lines (MCF7 and SKBR3): A systematic review

Abstract

Herbal drug development is considered as an imperative part of complementary and alternative medicine. Bioactive compounds of botanical sources represent potential anti-cancer agents for modern therapeutics. Primary in vitro data of herb extracts’ effects against cancer cell lines could be considered as indicators of potential toxicity to reduce the number of in vivo experiments. This study aims to review the findings of published articles concerning the in vitro efficacy of herbal extracts against breast cancer cell lines (MCF7 and SKBR3). In vitro studies of herbal extracts published until July 2018 were included in this review. Totally, nine extracts with IC50<4 exhibited the most inhibitory effect on breast cancer cell lines. This investigation has highlighted the fact that plant extracts have the potential to act as promising anticancer agents, making them appropriate components to be applied for chemoprevention or cancer treatment in case the researchers would find the right plant, the right solvent and the right fraction for the right disease.

Keywords

References

  1. [1] Riaz M, van Jaarsveld MT, Hollestelle A, Prager-van der Smissen WJ, Heine AA, Boersma AW, et al. miRNA expression profiling of 51 human breast cancer cell lines reveals subtype and driver mutation-specific miRNAs. Breast Cancer Res. 2013; 15(2): R33. [CrossRef]
  2. [2] Dai X, Cheng H, Bai Z, Li J. Breast cancer cell line classification and its relevance with breast tumor subtyping. J Cancer. 2017; 8(16): 3131-3141. [CrossRef]
  3. [3] Goodspeed A, Heiser LM, Gray JW, Costello JC. Tumor-derived cell lines as molecular models of cancer pharmacogenomics. Mol Cancer Res. 2016; 14(1): 3-13. [CrossRef]
  4. [4] Darvishi M, Esmaeili S, Dehghan-Nayeri N, Mashati P, Gharehbaghian A. Anticancer effect and enhancement of therapeutic potential of Vincristine by extract from aerial parts of Juniperus excelsa on pre-B acute lymphoblastic leukemia cell lines. J Appl Biomed. 2017; 15(3): 219- 226. [CrossRef]
  5. [5] Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin A, et al. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature. 2012; 483(7391): 603–607. [CrossRef]
  6. [6] Suffness M. Assays related to cancer drug discovery. Methods in plant biochemistry: assays for bioactivity. 1990; 6: 71-133.
  7. [7] Kroll DJ. Natural Compounds in Cancer Therapy: Promising Nontoxic Antitumor Agents from Plants and Other Natural Sources. J Nat Prod. 2001; 64(12): 1605-1606. [CrossRef]
  8. [8] Yuenyongsawad S, Bunluepuech K, Wattanapiromsakul C, Tewtrakul S. Anti-cancer activity of compounds from Cassia garrettiana heartwood. Songklanakarin J Sci Technol. 2014; 36(2): 189-194.

Details

Primary Language

English

Subjects

Pharmacology and Pharmaceutical Sciences (Other)

Journal Section

Review

Authors

Nasrin Dehghan-nayeri * This is me
Iran

Mina Darvishi This is me
Iran

Pargol Mashati This is me
Iran

Maryam Rezapour-kalkhoran This is me
Iran

Morteza Rezaiefard This is me
Iran

Samareh Younesian This is me
Iran

Publication Date

June 27, 2025

Submission Date

October 29, 2018

Acceptance Date

December 9, 2019

Published in Issue

Year 2020 Volume: 24 Number: 1

APA
Dehghan-nayeri, N., Darvishi, M., Mashati, P., Rezapour-kalkhoran, M., Rezaiefard, M., & Younesian, S. (2025). Comparison of cytotoxic activity of herbal extracts on the most commonly used breast cancer cell lines (MCF7 and SKBR3): A systematic review. Journal of Research in Pharmacy, 24(1), 1-22. https://doi.org/10.35333/jrp.2020.121
AMA
1.Dehghan-nayeri N, Darvishi M, Mashati P, Rezapour-kalkhoran M, Rezaiefard M, Younesian S. Comparison of cytotoxic activity of herbal extracts on the most commonly used breast cancer cell lines (MCF7 and SKBR3): A systematic review. J. Res. Pharm. 2025;24(1):1-22. doi:10.35333/jrp.2020.121
Chicago
Dehghan-nayeri, Nasrin, Mina Darvishi, Pargol Mashati, Maryam Rezapour-kalkhoran, Morteza Rezaiefard, and Samareh Younesian. 2025. “Comparison of Cytotoxic Activity of Herbal Extracts on the Most Commonly Used Breast Cancer Cell Lines (MCF7 and SKBR3): A Systematic Review”. Journal of Research in Pharmacy 24 (1): 1-22. https://doi.org/10.35333/jrp.2020.121.
EndNote
Dehghan-nayeri N, Darvishi M, Mashati P, Rezapour-kalkhoran M, Rezaiefard M, Younesian S (June 1, 2025) Comparison of cytotoxic activity of herbal extracts on the most commonly used breast cancer cell lines (MCF7 and SKBR3): A systematic review. Journal of Research in Pharmacy 24 1 1–22.
IEEE
[1]N. Dehghan-nayeri, M. Darvishi, P. Mashati, M. Rezapour-kalkhoran, M. Rezaiefard, and S. Younesian, “Comparison of cytotoxic activity of herbal extracts on the most commonly used breast cancer cell lines (MCF7 and SKBR3): A systematic review”, J. Res. Pharm., vol. 24, no. 1, pp. 1–22, June 2025, doi: 10.35333/jrp.2020.121.
ISNAD
Dehghan-nayeri, Nasrin - Darvishi, Mina - Mashati, Pargol - Rezapour-kalkhoran, Maryam - Rezaiefard, Morteza - Younesian, Samareh. “Comparison of Cytotoxic Activity of Herbal Extracts on the Most Commonly Used Breast Cancer Cell Lines (MCF7 and SKBR3): A Systematic Review”. Journal of Research in Pharmacy 24/1 (June 1, 2025): 1-22. https://doi.org/10.35333/jrp.2020.121.
JAMA
1.Dehghan-nayeri N, Darvishi M, Mashati P, Rezapour-kalkhoran M, Rezaiefard M, Younesian S. Comparison of cytotoxic activity of herbal extracts on the most commonly used breast cancer cell lines (MCF7 and SKBR3): A systematic review. J. Res. Pharm. 2025;24:1–22.
MLA
Dehghan-nayeri, Nasrin, et al. “Comparison of Cytotoxic Activity of Herbal Extracts on the Most Commonly Used Breast Cancer Cell Lines (MCF7 and SKBR3): A Systematic Review”. Journal of Research in Pharmacy, vol. 24, no. 1, June 2025, pp. 1-22, doi:10.35333/jrp.2020.121.
Vancouver
1.Nasrin Dehghan-nayeri, Mina Darvishi, Pargol Mashati, Maryam Rezapour-kalkhoran, Morteza Rezaiefard, Samareh Younesian. Comparison of cytotoxic activity of herbal extracts on the most commonly used breast cancer cell lines (MCF7 and SKBR3): A systematic review. J. Res. Pharm. 2025 Jun. 1;24(1):1-22. doi:10.35333/jrp.2020.121

Cited By